Crizotinib/osimertinibVarious toxicity followed by drug-resistance: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1860卷 / 1期

关键词：

D O I：

10.1007/s40278-021-97589-z

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：134 / 134

相关论文

共 50 条

[11] AntiviralsAcquired drug resistance and drug toxicity: case report
Reactions Weekly, 2020, 1819 (1) : 53 - 53
[12] Cisplatin/crizotinib/pemetrexedLack of efficacy and acquired drug resistance: case report
Reactions Weekly, 2022, 1894 (1) : 110 - 110
[13] Crizotinib/nedaplatin/pemetrexedLack of efficacy and development of drug resistance: case report
Reactions Weekly, 2021, 1851 (1) : 120 - 120
[14] Crizotinib/erlotinib/osimertinibAcquired drug resistance in pulmonary adenocarcinoma: case report
Reactions Weekly, 2018, 1721 (1) : 96 - 96
[15] Crizotinib/vemurafenibDevelopment of resistance in metastatic colorectal cancer followed by cancer progression: case report
Reactions Weekly, 2017, 1673 (1) : 135 - 135
[16] AlectinibLiver toxicity and drug resistance: case report
Reactions Weekly, 2019, 1735 (1) : 21 - 21
[17] OsimertinibVarious toxicities: case report
Reactions Weekly, 2017, 1670 (1) : 218 - 218
[18] MeropenemDevelopment of drug-resistance and cross-resistance in Pseudomonas aeruginosa: case report
Reactions Weekly, 2018, 1720 (1) : 164 - 164
[19] CrizotinibAcquired resistance to crizotinib: case report
Reactions Weekly, 2019, 1762 (1) : 125 - 125
[20] Crizotinib/lorlatinibDrug resistance: case report
Reactions Weekly, 2022, 1928 (1) : 145 - 145

← 1 2 3 4 5 →